Table 1 Baseline patient demographics and disease characteristics (safety population)

 Female

6 (67)

5 (63)

6 (86)

17 (71)

 Male

3 (33)

3 (38)

1 (14)

7 (29)

 White

9 (100)

7 (88)

7 (100)

23 (96)

 Black

0

1 (13)

0

1 (4)

Age, years^a

56 (29–65)

59 (43–65)

59 (36–75)

59 (29–75)

BMI, kg/m^2b

27.37 (2.246)

24.69 (2.471)

28.30 (1.778)

26.75 (2.607)

Disease duration, years

3.3 (0.9–10.9)

4.9 (1.7–19.0)

5.2 (3.0–9.3)

4.4 (0.9–19.0)

DAS28-ESR^b

4.8 (0.41)

4.9 (0.35)

4.4 (0.59)

4.7 (0.48)

DAS28-CRP^b

4.4 (0.82)

4.2 (0.52)

4.0 (0.62)

4.2 (0.65)

ESR, mm/hour^b

31 (11.91)

28 (5.56)

23 (8.06)

28 (9.31)

CRP, mg/liter^b

21 (22.64)

8 (6.75)

12 (10.44)

13 (15.43)

TJC^b (0–68)

8.7 (5.45)

9.1 (6.92)

9.6 (4.69)

9.1 (5.55)

SJC^b (0–66)

5.0 (5.41)

4.3 (2.38)

6.1 (5.30)

5.1 (4.45)